The 100 most cited psoriasis articles in clinical dermatologic journals, 1970 to 2012

Journal of Clinical and Aesthetic Dermatology

Volumn 7, Issue 10, 2014, Pages 10-19

  Wu, Jashin J ^a   Choi, Young M ^b   Marczynski, Wojciech ^c  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INDIANA UNIVERSITY SOUTH BEND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CITATION ANALYSIS; DERMATOLOGY; GERMANY; HUMAN; MEDICAL LITERATURE; PSORIASIS; SCISEARCH; UNITED KINGDOM; UNITED STATES;

EID: 84910032826     PISSN: 19412789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Icen M, Crowson CS, McEvoy MT, et al. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009;60(3):394-401.
2. Chaudhari U, Romano P, Mulcahy LD, et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet. 2001;357(9271):1842-1847.
3. Leonardi CL, Powers JL, Matheson RT, et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med. 2003;349(21):2014-2022.
4. Gordon KB, Langley RG, Leonardi C, et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol. 2006;55(4): 598-606.
5. Dommasch ED, Abuabara K, Shin DB, et al. The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2011;64(6):1035-1050.
6. Rustin MH. Long-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data. Br J Dermatol. 2012;167(Suppl 3):3-11.
7. Leonardi C, Matheson R, Zachariae C, et al. Anti-interleukin-17 monoclonal antibody Ixekizumab in chronic plaque psoriasis. N Engl J Med. 2012;366(13):1190-1199.
8. Papp KA, Leonardi C, Menter A, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012;366(13):1181-1189.
9. Hugh J, Van Voorhees AS, Nijhawan RI, et al. The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2013 Oct; [Epub ahead of print].
10. Lefaivre KA, Shadgan B, O'Brien PJ. 100 most cited articles in orthopaedic surgery. Clin Orthop Relat Res. 2011;469(5): 1487-1497.
11. Yoon DY, Yun EJ, Ku YJ, et al. Citation classics in radiology journals: the 100 top-cited articles, 1945-2012. AJR Am J Roentgenol. 2013;201(3):471-481.
12. Brandt JS, Downing AC, Howard DL, et al. Citation classics in obstetrics and gynecology: the 100 most frequently cited journal aticles in the last 50 years. Am J Obstet Gynecol. 2010;203(4):355.e1-e7.
13. Dubin D, Häfner AW, Arndt KA. Citation classics in clinical dermatologic journals. Citation analysis, biomedical journals, and landmark articles, 1945-1990. Arch Dermatol. 1993;129(9):1121-1129.
14. Stern RS, Arndt KA. Top cited authors in dermatology: a citation study from 24 journals: 1982-1996. Arch Dermatol. 1999;135(3):299-302.
15. Wu JJ, Ramirez CC, Alonso CA, et al. Ranking the dermatology programs based on measurements of academic achievement. Dermatol Online J. 2007;13(3):3.
16. Mueller W, Herrmann B. Cyclosporin A for psoriasis. N Engl J Med. 1979;301(10):555.
17. Sabat R, Sterry W, Philipp S, Wolk K. Three decades of psoriasis research: where has it led us? Clin Dermatol. 2007;25(6):504-509.
18. Gottlieb AB, Matheson RT, Lowe N, et al. A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol. 2003;139(12):1627-1632.
19. Gordon KB, Langley RG, Leonardi C, et al. Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol. 2006;55(4): 598-606.
20. Gottlieb AB, Evans R, Li S, et al. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2004;51(4):534-542.